Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: The role of folate supplementation

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 2, 2007, Pages 130-135

  Villa, Paola ^a   Suriano, Rosanna ^a   Costantini, Barbara ^a   Macrì, Francesca ^a   Ricciardi, Luigi ^a   Campagna, Giuseppe ^a   Lanzone, Antonio ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Cardiovascular disease; Endothelium; Folate; Homocysteine; Postmenopausal

Indexed keywords

ESTRADIOL; ESTROGEN; FOLIC ACID; GESTAGEN; HOMOCYSTEINE; LIPID; PLACEBO;

ARTERY ENDOTHELIUM; BRACHIAL ARTERY; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MEMBRANE; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS INFUSION; DATA ANALYSIS; DIET SUPPLEMENTATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONE SUBSTITUTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIPID METABOLISM; METABOLIC SYNDROME X; NUTRITIONAL STATUS; POSTMENOPAUSE; PRIORITY JOURNAL;

CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; FEMALE; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; POSTMENOPAUSE;

EID: 33847093875     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.067     Document Type: Conference Paper

References (50)

1. Falkeborn M, Schairer C, Naessen T, Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol 2000;53:832-7.
2. Wouters MG, Moorrees MT, Van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801-5.
3. Hak AE, Polderman KH, Westerdorp IC, Jacobs C, Hofman A, Witteman JC, et al. Increased plasma homocysteine after menopause. Atherosclerosis 2000;149:163-8.
4. Morris M, Jacques P, Selhub J, Rosenberg I. Total homocysteine and estrogen status indicators in the Third National Health and Nutritional Examination Survey. Am J Epidemiol 2000;152:140-8.
5. Van Baal WM, Smolders RG, Van der Mooren MJ, Teerlink T, Kenemans P. Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol 1999;94:485-91.
6. Bernabei VM, Phillips TM, Hsia J. Plasma homocysteine in women taking hormone replacement therapy: the postmenopausal estrogen/progestin interventions (PEPI) trial. J Womens Health Gend Based Med 1999;8:1167-72.
7. Berger PB, Herrmann RR, Dumesic DA. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo Clin Proc 2000;75:18-23.
8. Evio S, Tiitinen A, Turpeinen U, Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil Steril 2000;74:1080-3.
9. Ventura P, Cagnacci A, Malmusi S, Panini R, Baldassarri F, Arangino S, et al. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. Menopause 2001;8:252-8.
10. Chiantera V, Sarti CD, Fornaio F, Farzati A, De Franciscis P, Sepe E, et al. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Menopause 2003;10:286-91.
11. Smolders RG, Van der Mooren MJ, Teerlink T, Merkus JM, Kroeks MV, Franke HR, et al. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels. Fertil Steril 2003;79:261-7.
12. Lacut K, Oger E, Abalain JK, Moineau MP, Mottier D, SARAH investigators. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial. Atherosclerosis 2004;174:173-80.
13. Ghezzi F, Buttarelli M, Cromi A, Raio L, Cedars M, Bolis P. Plasma homocysteine levels after hormone therapy with and without folic acid supplementation: a randomized study. Fertil Steril 2004;82:746-8.
14. Smolders RG, de Meer K, Kenemans P, Teerlink T, Jakobs C, Van der Mooren MJ. Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in post-menopausal women. Eur J Obstet Gynecol Reprod Biol 2004;117:55-9.
15. Dimitrova KR, DeGroot K, Myers AK, Kim YD. Estrogen and homocysteine. Cardiovasc Res 2002;53:577-88.
16. Reimann M, Vafeiadou K, Hall WL, Dierkes J, Nilsson M, Dahlman-Wright K, et al. Evidence for associations between common polymorphisms of estrogen receptor beta gene with homocysteine and nitric oxide. Climacteric 2006;9:215-23.
17. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in the elderly. J Am Med Assoc 1993;270:2693-8.
18. Van Der Gried R, Biesma DH, Haas FJ, Faber JA, Duran M, Meuwissen OJ, et al. The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations. J Intern Med 2000;248:223-9.
19. Masse PG, Dosy J, Cole DE, Evrovski J, Mahuren JD, Coburn SP. Elevation of plasma homocysteine in natural menopause cannot be explained by a lack of vitamin coenzyme availability: relevance to the risk of cardiovascular disease. J Nutr Health Aging 2005;9:59-64.
20. Toprak A, Erenus M, Ilhan AH, Haklar G, Fak AS, Oktay A. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level. Climacteric 2005;8:279-86.
21. Saez G, Thornalley PJ, Hill HA, Herms R, Bannister JV. The production of free radicals during the autooxidation of cysteine and their effect on isolated rat hepatocytes. Biochim Biophys Acta 1982;719:24-31.
22. Hellsten Y, Svensson M, Sjodin B, Smith S, Christensen A, Richter EA, et al. Allantoin formation and urate and glutathione exchange in human muscle during submaximal exercise. Free Radical Biol Med 2001;31:1313-22.
23. Ueland PM, Mansoor MA, Guttormsen AB. Reduced, oxidised and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiols status - a possible element of the extracellular antioxidant defence system. J Nutr 1996;126:1281S-4S.
24. Scott JM. Homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:333-4.
25. Olszewski AJ, McCully KS. Homocysteine content of lipoproteins in hypercholesterolaemia. Atherosclerosis 1991;88:61-8.
26. Earnest CP, Wood KA, Church TS. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation. J Am Coll Nutr 2003;22:400-7.
27. Villa P, Perri C, Suriano R, Cucinelli F, Panunzi S, Mele C, et al. L-Folic acid supplementation in healthy post-menopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab 2005;90:4622-9.
28. De Leo V, La Marca A, Morgante G, Ciani F, Zammarchi E, Setacci C. Low dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women. Am J Obstet Gynecol 2000;183:945-7.
29. Van der Griend R, Haas FJ, Biesma DH, Duran M, Menwissen OJ, Banga JD. Combination of low dose folic acid and pyridoxine for treatment of hyperhomocysteinemia in patients with premature arterial disease and their relatives. Atherosclerosis 1999;143:177-83.
30. McCarty MF. Increased homocysteine associated with smoking, chronic inflammation, and ageing may reflect acute phase induction of pyridoxal phosphatase activity. Med Hypotheses 2000;55:289-93.
31. Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 1998;83:550-3.
32. McCarty MF. Insulin secretion a potential determinant of homocysteine levels. Med Hypotheses 2000;55:454-5.
33. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 2001;24:1403-10. 34. Sheu WH, Lee WJ, Chen YD. Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Hypertens 2001;13:14-20.
34. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003;18:721-7.
35. Dicker-Brown A, Fonseca VA, Fink LM, Kem PA. The effect of glucose and insulin on the activity of enzymes in homocysteine metabolism. Diabetes 1999;48(Suppl 1):A135.
36. Meigs JB, Jacques PF, Selhub J, Sunger DE, Nathan DM, Rifai N, et al.; Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 2001;24:1403-10.
37. Gillum R. Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: the Third National Health and Nutrition Examination Survey. Nutrition J 2003;2:6-13.
38. Abbasi F, Facchini F, Humphreys MH, Reaven GM. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin mediated glucose disposal. Atherosclerosis 1999;146:175-8.
39. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001;86:719-23.
40. Setola E, Monti LD, Galluccio E, Pallosi A, Fracasso G, Paroni R, et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 2004;151:483-9.
41. Stehouwer CD, Van Guldener C. Does homocysteine cause hypertension? Clin Chem Lab Med 2003;41:1408-11.
42. Woo KS, Chook P, Chan LL, Cheung AS, Fung WH, Qiao M, et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 2002;112:535-9.
43. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 2006;91:308-18.
44. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-6.
45. Rasmussen LB, Ovesen L, Bulow I, Knudsen N, Laurberg P, Perrild H. Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women. Am J Clin Nutr 2000;72:1156-63.
46. Paradisi G, Cucinelli F, Mele MC, Barini A, Lanzone A, Caruso A. Endothelial function in post-menopausal women: effect of folic acid supplementation. Human Reprod 2004;19:1031-5.
47. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002;105:22-6.
48. Stroes ES, van Faassen EE, Yo M, Martasek P, Boer P, Govers R, et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 2000;86:1129-34.
49. Doshi SN, McDowell IF, Moat SJ, Lang D, Newcombe RG, Kredan MB, et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol 2001;21:1196-202.
50. Ziakka S, Rammos G, Kountouris S, Doulgerakis C, Karakasis P, Kourvelou C, et al. The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis. Int Urol Nephrol 2001;33:559-62.